CompletedPhase 4

Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1

Brazil42 participantsStarted 2022-03-16

Plain-language summary

In this study the investigators compare the parasacral transcutaneous electric nerve stimulation (PTENS) treatment with Darifenacin to improve OAB symptoms in patients infected with HTLV-1.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * HTLV-1 infection * Overactive bladder symptom * 18 years of age or older Exclusion Criteria: * HTLV-1 infected subjects with HAM * Stroke * Parkinson * HIV infection * Prostatic hyperplasia * Pacemaker use * Genitourinary tract infection * Glaucoma

What they're measuring

Overactive Bladder Symptom Score

Timeframe: 2 months or 20 sessions

Trial details

NCT IDNCT06616675

SponsorHospital Universitário Professor Edgard Santos

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-20

View on ClinicalTrials.gov More HTLV-1 trials